{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,12]],"date-time":"2023-10-12T10:32:22Z","timestamp":1697106742804},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CDTIEMD"],"published-print":{"date-parts":[[2002,7,1]]},"DOI":"10.2174\/1568008023340703","type":"journal-article","created":{"date-parts":[[2006,3,4]],"date-time":"2006-03-04T11:06:44Z","timestamp":1141470404000},"page":"109-118","source":"Crossref","is-referenced-by-count":4,"title":["Recombinant Adenovirus-mediated Cytotoxic Gene Therapy and Lymphoproliferative Disorders: Analysis Based on Pharmacodynamics"],"prefix":"10.2174","volume":"2","author":[{"given":"Francesco","family":"Turturro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Current Drug Target - Immune, Endocrine & Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/92015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T05:08:25Z","timestamp":1448860105000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/openurl\/content.php?genre=article&issn=1568-0088&volume=2&issue=2&spage=109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,1]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,7,1]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1568008023340703","relation":{},"ISSN":["1568-0088"],"issn-type":[{"value":"1568-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2002,7,1]]}}}